The DOJ and HHS reestablish the False Claims Act Working Group to enhance enforcement against healthcare fraud and abuse in federal programs, emphasizing compliance and whistleblower roles.

The HHS Office of Inspector General identifies $17 billion in potential cost savings by improving program efficiency and compliance in healthcare programs.

Updates on U.S. healthcare budget reconciliation delays, Medicaid policy debates, Medicare Advantage lawsuits, HHS budget for FY 2026, and new NIH research initiatives shaping insurance and healthcare regulation.

The Supreme Court case over PSTF appointment authority could impact ACA preventive care coverage like PrEP and cancer screenings, with broad implications for insurance mandates and healthcare policy.

April 2025 update on U.S. pharmaceutical regulation highlights executive orders, budget changes, CMS policies, IRA litigation, and 340B program developments shaping drug pricing and access.

Chiquita Brooks-LaSure highlights critical issues from cuts in HHS that threaten nursing home oversight, impacting care quality and enforcement.